Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
暂无分享，去创建一个
J. Perfect | S. Holland | J. Sobel | J. Wingard | T. Calandra | C. Viscoli | B. Kullberg | D. Stevens | J. Graybill | W. Graninger | D. Kontoyiannis | T. Walsh | J. Bennett | E. Bow | C. Cordonnier | B. D. de Pauw | R. Herbrecht | L. Wheat | T. Patterson | J. Maertens | W. Dismukes | M. Viviani | B. Dupont | L. Ostrosky-Zeichner | J. Billé | P. Pappas | C. Kauffman | L. Baden | B. Segal | N. Almyroudis | David A. Stevens | D. Stevens | B. Pauw | D. Stevens